9 nov 2021
CPhI Worldwide 2021

About us

GEROPHARM is one of the leaders in the field of biotechnology products used for diabetes treatment. Company is specializing in full-cycle drug development and production of insulin products (rh-insulins, insulin glargine, lispro & lispro mix, aspart & aspart mix, degludec). GEROPHARM expertise also covers neurology, ophthalmology, endocrinology and gynecology therapeutic areas. GEROPHARM production facilities (two manufacturing plants) fully comply with ISO 9001 and GMP standard.

Specs about this supplier

Sales markets Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Affiliated categories: Biopharmaceuticals |Biosimilars More

Products featured at CPhI Worldwide 2021

Categories affiliated with Geropharm


Event information

CPhI Worldwide 2021

9-11 November 2021 Fiera Milano, Milan, Italy Visit us at stand 1B51